MétaCan
Menu
Back to cohort
Record W2253754608 · doi:10.1093/jtm/tav009

Malaria prevention—keep it simple and logical

2016· article· en· W2253754608 on OpenAlexaboutno aff
Martin Haditsch

Bibliographic record

VenueJournal of Travel Medicine · 2016
Typearticle
Languageen
FieldMedicine
TopicTravel-related health issues
Canadian institutionsnot available
Fundersnot available
KeywordsMalariaMedicineIndigenousTravel medicinePopulationScarcityEnvironmental healthPsychiatryImmunology

Abstract

fetched live from OpenAlex

Due to various activities—including those by the World Bank and the Bill & Melinda Gates Foundation—we are happy to see a global decrease in malaria cases. But too many still suffer and die from malaria so malaria prevention or at least to prevent deaths by malaria is of paramount importance, still. And this is not true for the indigenous population only but for travellers as well. Balancing the risk of disease with that of possible side effects of chemoprophylaxis is a difficult task which mostly leads to split decisions even in experts (as was shown in a thrilling Pro-Con debate at the CISTM14 in Quebec in May 2015). This lack of guidance left and still leaves many colleagues (including qualified travel medicine practitioners) quite puzzled—not to talk about those on target—i.e. the travellers. For sustainable guidance my deep believe is: KEEP IT SIMPLE—otherwise counselling doctors (not all of whom are experts in tropical medicine or malariology) as well as travellers will get lost in confusion for sure1 (‘The compliance is inversely proportional to the complexity of the prescription’—Haynes and Sackett 1976). Insect bite precautions (IBP) from dusk until dawn are the mainstay of malaria prophylaxis—so this is of paramount importance for each traveller going to malaria endemic areas no matter how high the risk actually is. The first crucial decision of the binary decision tree is the definition of high risk of exposure (but may consider high risk of complications in vulnerable travellers as well). Whereas some sources say that there is no method of quantifying the risk2 in other sources high risk is defined by a risk of 10:1000 in the indigenous population3 or 1:100 (or higher)/month of stay (e.g. for tropical Africa—older data: incidence of malaria per month of exposure for travellers not taking chemoprophylaxis: 15.2 per 1000 in East Africa and 24.2 per 1000 in West Africa4). Highly endemic throughout the year are most countries in tropical Africa, some islands in the Pacific Ocean and—at the moment—shrinking areas of tropical South America (to be looked up in actual malaria maps from various organizations). In these regions, the recommended strategy is chemoprophylaxis (with active compounds in addition to insect protection) —no matter how long the stay is (in some areas in West Africa the average likelihood of having an infectious bite is >1/night !5). In regions with a high annual variability of risk chemoprophylaxis (+IBP) should be limited to the high risk seasons, only. MISCONCEPTIONS DUE TO WORDING The wording “stand by therapy or treatment (SBT)” [10] always leaves me with huge discomfort and I would re-emphazise to replace it in general by the expression “emergency self treatment” or “emergency self therapy” (EST)**. The reason to push “EST” is that “stand by” might be dangerously misleading. At least it plays a critical strategy (which is not even state of the art globally) down in putting travellers to increased risk based on misconception (which is - amongst several other cases dramatically illustrated by an Austrian traveller to Lombok who died in Austria due to malaria while still having atovaqone/proguanil in his pocket). For clarification: emergency self treatment (EST) is applied by (mostly lay) people based on symptoms typical for malaria (which also means that they must know the symptoms as well as the minimal incubation period) if they have no or delayed access only to qualified medical care. The goal of this (primarily European) approach is to bridge the gap in between onset of symptoms and qualified medical care to positively impact the course of a potentially life threatening disease. By using the expression “EST” the traveller knows that this is for emergency use (i.e. dealing with a dangerous disease), done by her-/himself (which indicates self-responsibility for correct intake) as a pre-emptive treatment (i.e. highly active medical compounds which might cause side effects as well). This kind of strategy implies that the traveller needs to be trained and should get a written information on the initial symptoms (when to start the drug), the prescribed drug (i.e. how to take it: dosing, interval, duration, cofounding factors and additional aspects like impact of food on absorption and possible side effects) and what to do in case of vomiting. And most importantly to go and see a doctor as soon as possible no matter whether the symptoms improved after taking the drug since this might be due to unspecific actions of the drug, to the natural course of a disease other than malaria (e.g. a bacterial sepsis) or might camouflage partially resistant malaria parasites, respectively. Under the bottom-line if given in a correct way for the counsellor giving instructions for EST are more time consuming by far as compared to providing those for malaria chemoprophylaxis. And the action required, i.e. self-medication based on clinical symptoms is by far more difficult for the traveller. While this is adequately reflected by the wording “emergency self treatment” the expression “stand by” does not mirror this situation in any instance - thus bearing the risk of gross underestimation. To avoid any further misconceptions I propose to eliminate the term “stand by” from all official malaria literature. **IAMAT has already agreed to change all wordings accordingly. For other regions and/or seasons with moderate or low risk6 (in the actual scientific literature there are no clear data how to discriminate these both groups; the API always relates to the risk of the local population and is of limited—if any—value for travellers; regions with a high annual variability between high and low should not be addressed as ‘moderate’ just by calculating the average perennial risk) prophylaxis is limited to IBP. The additional (and frankly spoken most confusing) challenge is whether for these trips drugs for emergency self-treatment (EST) should be recommended or not: If the end of the trip to a non-high-risk region is earlier than the minimal incubation period no additional action is needed. So there is no need to carry drugs for EST, too. If the stay is longer the decision should be based on the accessibility to qualified medical care, which includes exact diagnosis and proper treatment. Proper treatment excludes over-the-counter products that might be fake or of bad quality due to production, shipping or storage. As a result qualified medical care usually is limited to hospitals and officially certified health care centres. Since as to my knowledge not even P. knowlesi (the fastest replicating plasmodial parasite) caused fatal courses of malaria within 24 h from the first (!) signs of infection and the course of disease is comparable to P. falciparum infection this time frame7 could be used for further decisions: if qualified medical services can be provided within 24 h (which is true in general for most of the travellers) no additional action is needed. So there is no need to carry drugs for EST, too. Consequently, EST should be provided only for travellers to remote areas (i.e. when qualified medical services cannot be approached within 24 h) where the malaria risk is (moderate to) low. As a summary + chemoprophylaxis in addition to insect bite prevention should be recommended for (seasonal or perennial) high risk areas (or for travellers with a high risk of complications in case of malaria) + insect bite prevention only if the trip is to regions/in seasons/under conditions with (moderate to) low risk of exposure and shorter than 6 days or for longer trips if medical care can be accessed within 24 h and + EST for longer trips to remote areas (i.e. with no access to qualified medical care within 24 h) with (moderate to) low malaria risk. Since, we are dealing with a potentially life threatening disease adherence to each detail of this decision-making process is crucial. Anyhow a scheme based on three basic decisions (risk of exposure—duration of stay—access to qualified medical care: flowchart see Figure 1) should make this complex challenge simple enough to provide satisfying and uniform guidance for counselling nurses, pharmacists and doctors and accomplish the goal to improve adherence of travellers to the recommendations given.8,9 Malaria prevention in travellers Conflict of interest: None declared.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.025
metaresearch head score (Gemma)0.083
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.025
Threshold uncertainty score0.134

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0250.083
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0020.001
Science and technology studies0.0040.012
Scholarly communication0.0130.025
Open science0.0040.007
Research integrity0.0070.025
Insufficient payload (model declined to judge)0.0160.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.370
Teacher spread0.309 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Travel MedicineSame topicTravel-related health issuesFrench-language works237,207